Laura Hondebrink

I am a European Registered Toxicologist (ERT) with over a decade of experience in neurotoxicity and the clinical toxicology of recreational drugs, including new psychoactive substances (NPS).

My expertise focuses on the assessment of acute drug toxicity, like MDMA, nitrous oxide, and emerging substances, with direct relevance for clinical decision-making and public health.

As a Senior Scientist at the Dutch Poisons Information Center (DPIC), I lead national and international research programmes in clinical toxicology and toxicovigilance. My work centres on human observational studies, integrating poison centre data and surveillance signals to detect emerging drug-related risks and trends.

I have authored 50+ peer-reviewed publications, 80+ conference abstracts, and ~20 contributions to press outlets, addressing toxicity mechanisms, clinical outcomes, and risk assessment of recreational drugs to support evidence-based guidance for healthcare professionals, regulators, and policymakers.

In parallel with my scientific activities, I have extensive experience in professional governance within national and European toxicology networks. I currently serve as Treasurer of the Dutch Society of Toxicology (NVT). Previously, I served on the Board of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) as a member of the board and Scientific Committee (2020–2024), and General Secretary (2022–2024).

My aim is to strengthen the evidence base for clinical management, public health policy, and risk communication related to recreational drug poisonings.